Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Compass Therapeutics, Inc. Common Stock · CMPX

CMPXNASDAQCommon stockCurrentCIK 1738021Updated Nov 22, 2026

Company: Compass Therapeutics, Inc. →

Name history
Olivia Ventures, Inc. · through Jun 8, 2020

CMPX price & chart

Provider market data

Loading TradingView…

NASDAQ:CMPX on TradingView ↗

TradingView · Data may be delayed

About the company

Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The Company was founded in 2014 and is headquartered in Boston, Massachusetts.

8-K · 2025-08-13 · 0001193125-25-179958

Company description from the cited filing.

In the news

Seeking Alpha

Financials

FY 2025 · USD
Revenue— · FY 2025
Net income-66,489,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

Operating income-72,839,000USD · FY 2025
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

Diluted EPS— · FY 2025

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q2 2026Q2 2025Q2 2024Q1 2026Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD231,259,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

149,151,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

190,173,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

116,698,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

155,611,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

205,170,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

131,451,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

161,142,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

219,588,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

140,403,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

156,875,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

199,645,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Property, Plant and Equipment, NetUSD119,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

493,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

324,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

131,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

592,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

169,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

102,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2025-03-31

744,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

102,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

353,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

898,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

1,567,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD46,212,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

19,404,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2024-09-30

35,453,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

22,856,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2025-06-30

19,404,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2024-06-30

55,168,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

41,048,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2025-03-31

43,483,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2024-03-31

30,643,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

43,483,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

24,228,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

34,946,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Assets, CurrentUSD221,120,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

141,140,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

180,890,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

106,195,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

153,546,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

195,687,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

124,145,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

158,611,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

209,819,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

132,751,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

153,881,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

194,791,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD1,225,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

5,738,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

1,011,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

5,246,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

7,319,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

1,000,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

11,510,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

2,356,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

913,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

6,029,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

1,420,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

8,182,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD9,452,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

6,950,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

8,391,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

9,804,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

1,153,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

8,746,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

6,507,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

1,467,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

9,099,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

6,731,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

1,776,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

2,967,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Other Assets, NoncurrentUSD—568,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

——320,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

——320,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

—568,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

320,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

320,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD21,646,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

10,753,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

24,124,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

23,491,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

9,507,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

18,697,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

21,172,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

4,082,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

22,797,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

15,170,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

8,337,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

18,007,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD53,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

14,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

18,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

14,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

14,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

18,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

14,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

14,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

18,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

14,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

13,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

13,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-415,456,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

-349,652,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

-474,643,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

-401,197,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

-339,171,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

-449,489,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

-381,316,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

-326,095,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

-431,172,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

-364,683,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

-315,308,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

-272,814,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD274,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

486,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

-251,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

208,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

-91,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

-159,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

190,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

-90,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

280,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

210,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

37,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

-302,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD209,613,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

138,398,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2024-09-30

166,049,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

93,207,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2025-06-30

146,104,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2024-06-30

186,473,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

110,279,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2025-03-31

157,060,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2024-03-31

196,791,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

125,233,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

148,538,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

181,638,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Additional Paid in Capital, Common StockUSD624,742,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

487,550,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

640,925,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

494,182,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

485,352,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

636,103,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

491,391,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

483,231,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

627,665,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

489,692,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

463,796,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

454,741,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Liabilities and EquityUSD231,259,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

149,151,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

190,173,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

116,698,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

155,611,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

205,170,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

131,451,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

161,142,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

219,588,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

140,403,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

156,875,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

199,645,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD12,412,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

4,433,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

16,128,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

13,858,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

9,507,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

10,279,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

14,900,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

3,893,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

13,968,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

8,874,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

7,801,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

16,169,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Operating Lease, Liability, CurrentUSD633,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

557,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

1,637,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

271,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

1,088,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

1,373,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

109,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

1,224,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

1,000,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

338,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

1,197,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

1,097,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Accounts Payable, CurrentUSD3,095,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

960,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

2,906,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

2,595,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

1,192,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

906,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

1,577,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

854,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

1,585,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

2,249,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

4,090,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

3,382,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD9,234,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

6,320,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

7,996,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

9,633,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

0
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

8,418,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

6,272,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

189,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

8,829,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

6,296,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

536,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

1,838,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Additional Financial Items
Accrued Liabilities, CurrentUSD8,684,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

2,916,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

As of 2024-09-30

11,585,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

10,992,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

As of 2025-06-30

7,227,000
Source

10-Q · 2024-08-12 · 0001171843-24-004670

As of 2024-06-30

8,000,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

13,214,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

As of 2025-03-31

1,815,000
Source

10-Q · 2024-05-13 · 0001171843-24-002785

As of 2024-03-31

11,383,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

6,287,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

As of 2024-12-31

2,514,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

As of 2023-12-31

11,690,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization———————
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

—
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

—
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

—
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

—
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

—
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Share-based Payment Arrangement, Noncash ExpenseUSD——————5,073,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

2,514,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

8,368,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

8,560,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

6,120,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

5,330,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————-679,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-672,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-664,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-1,841,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

708,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

2,515,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-17,269,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-13,208,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-49,143,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-44,855,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-40,618,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-34,125,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash AcquiredUSD———————————0
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Investing ActivitiesUSD——————38,429,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

11,588,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-93,306,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

46,772,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

26,965,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-151,200,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD——————82,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

18,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

25,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

44,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

30,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

212,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Payment, Tax Withholding, Share-based Payment ArrangementUSD——————489,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

815,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

1,027,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

232,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

159,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

—
Net Cash Provided by (Used in) Financing ActivitiesUSD——————3,365,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-815,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

129,609,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

17,338,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

2,935,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

75,757,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————24,525,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-2,435,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-12,840,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

19,255,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-10,718,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-109,568,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——46,780,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2025-09-30

19,404,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

As of 2024-09-30

36,021,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2026-06-30

23,424,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

As of 2025-06-30

55,736,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2026-03-31

41,616,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

As of 2025-03-31

31,211,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

As of 2025-12-31

———
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD———————————0
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——1,238,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

2,198,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

4,822,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

2,791,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

5,073,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

2,514,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

8,368,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

8,560,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

6,120,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

5,330,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

DepreciationUSD——————15,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

140,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

300,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

600,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

700,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

800,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant EquipmentUSD——————————0
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

70,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——2,991,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

3,627,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

7,403,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

4,651,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

6,909,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

4,912,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

16,870,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

15,133,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

12,243,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

11,658,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD———————0
Source

10-Q · 2025-05-08 · 0001171843-25-002953

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Investment Income, InterestUSD———1,800,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

2024-07-01 to 2024-09-30

—1,200,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

2025-04-01 to 2025-06-30

—1,300,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

2025-01-01 to 2025-03-31

6,400,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

7,300,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

7,869,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

2,360,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Marketable Securities, Unrealized Gain (Loss)USD——————439,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

20,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

70,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-173,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-339,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

302,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-14,259,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

-10,481,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

-25,154,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

-19,881,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

-18,317,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-16,633,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-66,489,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-49,375,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-42,494,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-39,225,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Operating ExpensesUSD——15,817,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

12,239,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

26,979,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

21,066,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

20,299,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

17,966,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

72,839,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

57,475,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

50,363,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

41,655,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——1,558,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

1,758,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

1,825,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

1,185,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

1,982,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

1,333,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

6,350,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

7,250,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

7,869,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

2,430,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Proceeds from Issuance of Common StockUSD———————0
Source

10-Q · 2025-05-08 · 0001171843-25-002953

2025-01-01 to 2025-03-31

137,999,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

18,113,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

3,126,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

76,237,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Proceeds from Stock Options ExercisedUSD——————3,854,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

0
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

1,275,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

62,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

15,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Revenue from Contract with Customer, Including Assessed TaxUSD——0
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

—0
Source

10-Q · 2025-08-11 · 0001171843-25-005261

2025-04-01 to 2025-06-30

——0
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

850,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2026Q2 2025Q1 2026Q1 2025FY 2025FY 2024FY 2023FY 2022
Operating Income (Loss)USD——-15,817,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

-12,239,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

-26,979,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

-21,066,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

-20,299,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-17,966,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-72,839,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-56,625,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-50,363,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-41,655,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Other Nonoperating Income (Expense)USD——1,558,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

1,758,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

1,825,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

1,185,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

1,982,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

1,333,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

6,350,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

7,250,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

7,869,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

2,430,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD———————-16,633,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

2025-01-01 to 2025-03-31

——-42,494,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-39,225,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD———————0
Source

10-Q · 2025-05-08 · 0001171843-25-002953

2025-01-01 to 2025-03-31

0
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

0
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

0
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

0
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-14,259,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

-10,481,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

-25,154,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

-19,881,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

-18,317,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-16,633,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-66,489,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-49,375,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-42,494,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-39,225,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-0.08
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

-0.08
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

-0.13
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

-0.14
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

-0.1
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

-0.12
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

-0.42
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

-0.36
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

-0.33
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

-0.37
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——168,782,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

137,589,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

186,798,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

138,282,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

186,400,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

138,236,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

157,695,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

137,384,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

127,027,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

105,186,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Additional Financial Items
Depreciation, Depletion and Amortization, NonproductionUSD——————15,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

140,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

276,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

589,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

699,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

782,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

General and Administrative ExpenseUSD——2,991,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

3,627,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

7,403,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

4,651,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

6,909,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

4,912,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

16,870,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

15,133,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

12,243,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

11,658,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Interest ExpenseUSD———————————0
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Investment Income, InterestUSD———1,800,000
Source

10-Q · 2024-11-12 · 0001171843-24-006248

2024-07-01 to 2024-09-30

—1,200,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

2025-04-01 to 2025-06-30

—1,300,000
Source

10-Q · 2025-05-08 · 0001171843-25-002953

2025-01-01 to 2025-03-31

6,400,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

7,300,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

7,869,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

2,360,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Operating ExpensesUSD——15,817,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

12,239,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

26,979,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2026-04-01 to 2026-06-30

21,066,000
Source

10-Q · 2026-08-06 · 0001171843-26-005295

2025-04-01 to 2025-06-30

20,299,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

17,966,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

72,839,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

57,475,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

50,363,000
Source

10-K · 2024-03-21 · 0001171843-24-001516

2023-01-01 to 2023-12-31

41,655,000
Source

10-K · 2023-03-15 · 0001171843-23-001691

2022-01-01 to 2022-12-31

Research and Development ExpenseUSD——12,826,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

8,612,000
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

—16,415,000
Source

10-Q · 2025-08-11 · 0001171843-25-005261

2025-04-01 to 2025-06-30

13,390,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2026-01-01 to 2026-03-31

13,054,000
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

55,969,000
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

42,342,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

——
Revenue from Contract with Customer, Including Assessed TaxUSD——0
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

—0
Source

10-Q · 2025-08-11 · 0001171843-25-005261

2025-04-01 to 2025-06-30

——0
Source

10-K · 2026-03-05 · 0001171843-26-001337

2025-01-01 to 2025-12-31

850,000
Source

10-K · 2025-02-27 · 0001171843-25-001106

2024-01-01 to 2024-12-31

——
Weighted Average Number of Shares Outstanding, Diluted————
Source

10-Q · 2025-11-05 · 0001171843-25-007005

2024-07-01 to 2024-09-30

————
Source

10-Q · 2026-05-05 · 0001171843-26-003006

2025-01-01 to 2025-03-31

————

Lines labelled “Derived” are calculated from reported figures.

Filing attachments

d153873dex41.htm · 8-K · 2025-08-13

EX-4.1 3 d153873dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK Number of Shares: [   ] (subject to adjustment) Warrant No. Original Issue Date: [ ], 2025 COMPASS THERAPEUTICS, INC. Compass Therapeutics, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ] or its registered assigns (the “Holder”), is entitled, subject to …

8-K · 2025-08-13 · 0001193125-25-179958

Read attachment ↗
d153873dex991.htm · 8-K · 2025-08-13

EX-99.1 5 d153873dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Compass Therapeutics Announces Proposed Public Offering BOSTON, August 12, 2025 - Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the launch of an underwritten public offering of its common stock and, in lieu of common stock to certain investors, pre-funded warrants …

8-K · 2025-08-13 · 0001193125-25-179958

Read attachment ↗
d153873dex992.htm · 8-K · 2025-08-13

EX-99.2 6 d153873dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering BOSTON, August 12, 2025 - Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the pricing of an underwritten public offering of 33,290,000 shares of its common stock at a price to the public o…

8-K · 2025-08-13 · 0001193125-25-179958

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.